Tullman Stephen A. 4
4 · Aclaris Therapeutics, Inc. · Filed Oct 5, 2018
Insider Transaction Report
Form 4
Tullman Stephen A.
Director
Transactions
- Purchase
Common Stock
2018-10-04$14.00/sh+7,100$99,370→ 177,457 total
Holdings
- 394,014(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 23, 2018.
- [F2]This transaction was executed in multiple trades at prices ranging from $13.90 to $14.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]These shares are held by the 2007 Irrevocable Trust of Stephen A. Tullman, for which the reporting person's spouse serves as the trustee.